CASTLE BIOSCIENCES INC Stockholders Equity

Quick Answer

CASTLE BIOSCIENCES INC reported Stockholders Equity of $470.87 million for fiscal year 2025.

CASTLE BIOSCIENCES INC Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $470.87M +3.3%
2024 $455.83M +16.5%
2023 $391.27M -2.0%
2022 $399.15M -3.1%
2021 $411.74M -1.0%
2020 $415.69M +388.4%
2019 $85.11M +250.5%
2018 -$56.57M -12.4%
2017 -$50.31M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $467.05M +5.9% +2.6%
June 30, 2025 $455.38M +7.4% +3.4%
March 31, 2025 $440.31M +9.4% -3.4%
December 31, 2024 $455.83M +16.5% +3.4%
September 30, 2024 $441.06M +14.3% +4.0%
June 30, 2024 $423.89M +11.9% +5.3%
March 31, 2024 $402.46M +4.5% +2.9%
December 31, 2023 $391.27M -2.0% +1.4%
  • CASTLE BIOSCIENCES INC showed an increase of +3.3% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2017–2025 period, CASTLE BIOSCIENCES INC’s stockholders equity has grown by 1035.9% (from -$50.31 million to $470.87 million).
  • The most recent figure is from CASTLE BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment